FDA NDC Directory · JSON-LD · Markdown

ARISTADA

NDC 65757-403 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, EXTENDED RELEASE

Generic namearipiprazole lauroxil
Labeler / ManufacturerAlkermes, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA207533
Dosage form / routeINJECTION, SUSPENSION, EXTENDED RELEASE · INTRAMUSCULAR
Active ingredientsARIPIPRAZOLE LAUROXIL (882 mg/3.2mL)
Marketing started20151005
Package count2

External sources

Source: openFDA. Public-domain (CC0).